Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation

Key Points Ascorbic acid facilitates KIR promoter demethylation in human NK cells. Runx3, TET2, and TET3 are enriched within KIR promoters in response to ascorbic acid. KIR expression is driven by the combination of Runx3, TET3, and ascorbic acid. Variegated expression of killer Ig-like receptors (KIR) in human NK cells is a stochastic process exclusive to subsets of mature NK cells and CD8+ T cells. Allele-specific KIR expression is maintained by DNA methylation within the proximal promoter regions. Because KIR genes are densely methylated in NK cell progenitors, there is an implied stage of human NK cell development in which DNA demethylation takes place to allow for active transcription. When and how this process occurs is unknown. In this study, we show that KIR proximal promoters are densely methylated in less mature CD56bright NK cells and are progressively demethylated in CD56dim NK cells as they mature and acquire KIR. We hypothesized that ten-eleven translocation (TET) enzymes, which oxidize 5mC on DNA could mediate KIR promoter demethylation. The catalytic efficiency of TET enzymes is known to be enhanced by ascorbic acid. We found that the addition of ascorbic acid to ex vivo culture of sorted CD56bright NK cells increased the frequency of KIR expression in a dose-dependent manner and facilitated demethylation of proximal promoters. A marked enrichment of the transcription factor Runx3 as well as TET2 and TET3 was observed within proximal KIR promoters in CD56bright NK cells cultured with ascorbic acid. Additionally, overexpression of TET3 and Runx3 promoted KIR expression in CD56bright NK cells and NK-92 cells. Our results show that KIR promoter demethylation can be induced in CD56bright, and this process is facilitated by ascorbic acid.

[1]  D. Schatz,et al.  TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the Aicda superenhancer , 2019, Science Immunology.

[2]  O. Pietiläinen,et al.  Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans , 2019, Nature Communications.

[3]  Bin Zhang,et al.  ARID5B regulates metabolic programming in human adaptive NK cells , 2018, The Journal of experimental medicine.

[4]  Harukazu Suzuki,et al.  A screening system to identify transcription factors that induce binding site-directed DNA demethylation , 2017, Epigenetics & Chromatin.

[5]  Y. Hayashizaki,et al.  RUNX1 regulates site specificity of DNA demethylation by recruitment of DNA demethylation machineries in hematopoietic cells. , 2017, Blood advances.

[6]  Harri Lähdesmäki,et al.  TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells , 2016, Nature Immunology.

[7]  P. Hogan,et al.  Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility , 2016, eLife.

[8]  Harri Lähdesmäki,et al.  Control of Foxp3 stability through modulation of TET activity , 2016, The Journal of experimental medicine.

[9]  Mi Hye Song,et al.  Vitamin C Facilitates Demethylation of the Foxp3 Enhancer in a Tet-Dependent Manner , 2016, The Journal of Immunology.

[10]  J. Issa,et al.  Minimal role of base excision repair in TET-induced global DNA demethylation in HEK293T cells , 2015, Epigenetics.

[11]  S. Balasubramanian,et al.  5-Hydroxymethylcytosine is a predominantly stable DNA modification. , 2014, Nature chemistry.

[12]  Bin Zhang,et al.  Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. , 2014, Blood.

[13]  S. Anderson,et al.  Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression , 2014, Genes and Immunity.

[14]  J. Klein,et al.  Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia , 2014, The Journal of Immunology.

[15]  M. Shirakawa,et al.  Cell Cycle-Dependent Turnover of 5-Hydroxymethyl Cytosine in Mouse Embryonic Stem Cells , 2013, PloS one.

[16]  G. Friedlander,et al.  Runx3-mediated Transcriptional Program in Cytotoxic Lymphocytes , 2013, PloS one.

[17]  Zechen Chong,et al.  Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. , 2013, Journal of the American Chemical Society.

[18]  Mohammad M. Karimi,et al.  Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells , 2013, Nature.

[19]  Mohammad M. Karimi,et al.  Vitamin C induces Tet-dependent DNA demethylation in ESCs to promote a blastocyst-like state , 2013, Nature.

[20]  Juan I. Young,et al.  Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine*♦ , 2013, The Journal of Biological Chemistry.

[21]  T. Down,et al.  Germline DNA Demethylation Dynamics and Imprint Erasure Through 5-Hydroxymethylcytosine , 2013, Science.

[22]  S. Gaines,et al.  The Mouse , 2011 .

[23]  A. Klein-Szanto,et al.  Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair , 2011, Cell.

[24]  G. Ming,et al.  Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain , 2011, Cell.

[25]  H. Ljunggren,et al.  Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. , 2010, Blood.

[26]  Chap T Le,et al.  Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. , 2010, Blood.

[27]  Yi Zhang,et al.  Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification , 2010, Nature.

[28]  S. Anderson,et al.  Cutting Edge: KIR Antisense Transcripts Are Processed into a 28-Base PIWI-Like RNA in Human NK Cells , 2010, The Journal of Immunology.

[29]  M. Caligiuri,et al.  CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. , 2010, Blood.

[30]  Albert Jeltsch,et al.  BISMA - Fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences , 2010, BMC Bioinformatics.

[31]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[32]  S. Anderson,et al.  The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element. , 2009, Blood.

[33]  Peter Parham,et al.  Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. , 2009, Blood.

[34]  M. Uhrberg,et al.  Lineage-Specific Transition of Histone Signatures in the Killer Cell Ig-Like Receptor Locus from Hematopoietic Progenitor to NK Cells1 , 2008, The Journal of Immunology.

[35]  P. Parham,et al.  A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. , 2007, Blood.

[36]  H. Trompeter,et al.  Epigenetic silencing of potentially functional KIR2DL5 alleles: Implications for the acquisition of KIR repertoires by NK cells , 2007, European journal of immunology.

[37]  T. Enver,et al.  CD56bright Human NK Cells Differentiate into CD56dim Cells: Role of Contact with Peripheral Fibroblasts , 2007, The Journal of Immunology.

[38]  P. Lansdorp,et al.  Telomere Length in Human Natural Killer Cell Subsets , 2007, Annals of the New York Academy of Sciences.

[39]  A. Thiel,et al.  CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1 , 2007, The Journal of Immunology.

[40]  S. Anderson,et al.  Identification of distal KIR promoters and transcripts , 2007, Genes and Immunity.

[41]  G. Davies,et al.  Identification of bidirectional promoters in the human KIR genes , 2007, Genes and Immunity.

[42]  C. Lutz,et al.  Epigenetic Control of Highly Homologous Killer Ig-Like Receptor Gene Alleles1 , 2005, The Journal of Immunology.

[43]  John X. Wilson.  Regulation of vitamin C transport. , 2005, Annual review of nutrition.

[44]  C. Le,et al.  Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. , 2005, Blood.

[45]  Michael J. Wilson,et al.  DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells , 2003, The Journal of experimental medicine.

[46]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[47]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[48]  R. Oostendorp,et al.  Stromal cell lines from mouse aorta-gonads-mesonephros subregions are potent supporters of hematopoietic stem cell activity. , 2002, Blood.

[49]  J. Trowsdale,et al.  Genetic and functional relationships between MHC and NK receptor genes. , 2001, Immunity.

[50]  M. Caligiuri,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset , 2001 .

[51]  T. Ghayur,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. , 2001, Blood.

[52]  Peter Parham,et al.  Gene Structure and Promoter Variation of Expressed and Nonexpressed Variants of the KIR2DL5 Gene1 2 , 2000, The Journal of Immunology.

[53]  S. Beck,et al.  Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  W. Reik,et al.  Active demethylation of the paternal genome in the mouse zygote , 2000, Current Biology.

[55]  J. Walter,et al.  Embryogenesis: Demethylation of the zygotic paternal genome , 2000, Nature.

[56]  M Plachot,et al.  Chromosome methylation patterns during mammalian preimplantation development. , 1998, Genes & development.

[57]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[59]  Jun Wu,et al.  Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.

[60]  Eric Vivier,et al.  Inhibition of antigen‐induced T cell response and antibody‐induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP‐1 and SHP‐2 protein‐tyrosine phosphatases , 1998, European journal of immunology.

[61]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[62]  É. Vivier,et al.  Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. , 1997, Journal of immunology.

[63]  Andrew G. Brooks,et al.  NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor , 1997, The Journal of experimental medicine.

[64]  L. Lanier,et al.  Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. , 1996, Journal of immunology.

[65]  D. Marguet,et al.  Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. , 1996, Journal of immunology.

[66]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[67]  P. Parham,et al.  The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. , 1995, Journal of immunology.

[68]  P. Parham,et al.  NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules , 1994, The Journal of experimental medicine.

[69]  J. Ritz,et al.  Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells , 1992, European journal of immunology.

[70]  M. Monk,et al.  Decrease in DNA methylase activity during preimplantation development in the mouse. , 1991, Development.

[71]  Z. Paroush,et al.  Dynamics of demethylation and activation of the α-actin gene in myoblasts , 1990, Cell.

[72]  E. Ciccone,et al.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition , 1990, The Journal of experimental medicine.

[73]  Z. Paroush,et al.  Dynamics of demethylation and activation of the alpha-actin gene in myoblasts. , 1990, Cell.

[74]  L. Lanier,et al.  Comparative studies of human FcRIII-positive and negative natural killer cells. , 1989, Journal of immunology.

[75]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.